Mir Imran, Rani CEO
Rani nabs $69M Series E for its stab at a robotic pill to replace injectable drugs
Rani Therapeutics has tapped the venture well again, this time raising a sweet $69 million for its push to make injectable medicines go down in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
